Segment Wealth Management LLC Buys New Position in Humana Inc. $HUM

Segment Wealth Management LLC purchased a new position in shares of Humana Inc. (NYSE:HUM) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 904 shares of the insurance provider’s stock, valued at approximately $221,000.

Several other institutional investors have also recently made changes to their positions in HUM. Vanguard Group Inc. increased its position in shares of Humana by 8.9% during the 1st quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider’s stock worth $3,697,222,000 after purchasing an additional 1,143,662 shares during the last quarter. AQR Capital Management LLC increased its position in shares of Humana by 3,257.5% during the 1st quarter. AQR Capital Management LLC now owns 1,162,600 shares of the insurance provider’s stock worth $307,624,000 after purchasing an additional 1,127,973 shares during the last quarter. Nuveen LLC acquired a new position in shares of Humana during the 1st quarter worth approximately $171,220,000. Dodge & Cox increased its position in shares of Humana by 5.5% during the 1st quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider’s stock worth $2,845,830,000 after purchasing an additional 557,175 shares during the last quarter. Finally, Pzena Investment Management LLC increased its position in shares of Humana by 6.1% during the 1st quarter. Pzena Investment Management LLC now owns 3,828,923 shares of the insurance provider’s stock worth $1,013,133,000 after purchasing an additional 219,541 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on HUM. Bank of America boosted their price target on Humana from $285.00 to $312.00 and gave the stock a “neutral” rating in a research report on Tuesday, September 2nd. Royal Bank Of Canada lifted their target price on Humana from $283.00 to $322.00 and gave the stock an “outperform” rating in a research note on Thursday, August 21st. Sanford C. Bernstein lifted their target price on Humana from $269.00 to $341.00 and gave the stock an “outperform” rating in a research note on Friday, September 5th. Evercore ISI initiated coverage on Humana in a research note on Monday, September 22nd. They set an “in-line” rating and a $295.00 target price for the company. Finally, Guggenheim reiterated a “buy” rating on shares of Humana in a research note on Friday. Seven research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $291.21.

Humana Stock Performance

HUM opened at $284.00 on Friday. The business has a fifty day simple moving average of $274.76 and a 200 day simple moving average of $257.35. The company has a market capitalization of $34.16 billion, a PE ratio of 21.80, a price-to-earnings-growth ratio of 1.67 and a beta of 0.42. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $315.35. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). The firm had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter last year, the firm earned $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. Research analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a $0.885 dividend. The ex-dividend date is Friday, September 26th. This represents a $3.54 annualized dividend and a yield of 1.2%. Humana’s payout ratio is 27.17%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.